My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2012
Patient Care and Science
C. difficile Updates, Related Sessions at IDWeek

Two recent developments related to Clostridium difficile treatment may be of interest to ID physicians, in addition to several relevant sessions at IDWeek 2012, Oct. 17-21, in San Diego, you won’t want to miss.

  • The Centers for Medicare and Medicaid Services (CMS) recently approved a temporary add-on payment for hospitals for fidaxomicin, an oral drug used to treat C. difficile-associated diarrhea. The add-on payments are part of a CMS program designed to remove barriers to access for costly new technologies that are not yet fully reflected in current CMS hospital payment rates.
  • The American Medical Association recently published a Current Procedural Terminology (CPT) code related to fecal transplantation. The new code is 44705, “Preparation of fecal microbiota for instillation, including assessment of donor specimen.” AMA’s CPT Changes: An Insider’s View 2013 may be helpful in understanding the application of this code.

Several sessions at IDWeek will focus on C. difficile prevention, diagnosis, treatment, and epidemiology, including:

Clostridium difficile and Host Defense
Symposium, Wednesday, Oct. 17, 1:30 - 3:30 p.m.
Room: SDCC 30 ABCDE

Update on Clostridium difficile Infection: Epidemiology, Diagnosis, and Treatment
Symposium, Thursday, Oct. 18, 2 - 3:30 p.m.
Room: SDCC Ballroom 6 DE

Clostridium difficile Infection
Meet-the-Professor Session, Saturday, Oct. 20, 7- 8:15 a.m.
Room: Marriott Hall 3

Related poster and oral abstract sessions are also scheduled:

C. difficile: Clinical and Outcomes
Poster Abstract Session, Thursday, Oct. 18, 12:30 - 2 p.m.
Room: SDCC Exhibit Hall D

C. difficile Diagnostics
Poster Abstract Session, Thursday, Oct. 18, 12:30 – 2 p.m.
Room: SDCC Exhibit Hall D

C. difficile Epidemiology
Poster Abstract Session, Thursday, Oct. 18, 12:30 – 2 p.m.
Room: SDCC Exhibit Hall D

C. difficile Prevention and Carriage
Poster Abstract Session, Thursday, Oct. 18, 12:30 – 2 p.m.
Room: SDCC Exhibit Hall D

C. difficile: Risk Factors and Outcomes
Oral Abstract Session, Friday, Oct. 19, 10:30 a.m. – noon
Room: SDCC 29 ABCD

Challenges in C. difficile Infection Surveillance
Oral Abstract Session, Saturday, Oct. 20, 10:30 a.m. – noon
Room: SDCC 29 ABCD


How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
Hospitals Required to Report HCW Influenza Vaccination Data in 2013
C. difficile Updates, Related Sessions at IDWeek
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
CMS to Include Maintenance of Certification in Incentive Program
Global ID
Thai HIV Vaccine Trial Yields More News
The Role of HIV-Related Stigma in Maternal Care in Kenya
HIV’s Impact on Men Who Have Sex with Men
Policy and Advocacy
IDSA Issues Updated Influenza Principles for U.S. Action
IDSA, HIVMA Urge Congress to Protect Public Health Funding
IDSA Offers Recommendations for Antibiotic Clinical Trial Designs
Action Needed to Address Resistance, Spur R&D, Expand Immunizations
Your Colleagues
Check Out “My IDSA” for Latest Member News
Top Stories
From the President: Volunteers Are Critical to IDSA’s Work
Updated Guideline on Group A Streptococcal Pharyngitis Now Online
EIN Update: West Nile Cases Underscore Lack of Treatment Data
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.